Delayed Prostate Cancer Therapy Monsey NY

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues.

Local Companies

Sushil Bhardwaj
(845) 368-8500
255 Lafayette Ave
Suffern, NY
MICHAEL RADER, MD
(845) 348-2198
160 N Midland Avenue
Nyack, NY
Omar El Ghandour, MD
315-474-4475
53 Skyline Dr
Saddle River, NJ
Michael Allan Schleider, MD
201-568-5250
25 Rockwood Pl
Englewood, NJ
Dr.Alan Israel
(201) 666-4949
270 Old Hook Road
Westwood, NJ
Zach Liu
(201) 791-2600
481 Edward H Ross Dr
Elmwood Park, NJ
Norman Lester Rosen
(914) 965-2060
3333 Henry Hudson Way
Bronx, NY
JULIE MONROE, MD
(914) 684-2779
2 Longview Avenue
White Plains, NY
Roman Perez Soler, MD
718-920-4001
Hofheimer Rm 100A 111 E 210th St
Bronx, NY
John Danl Del Rowe, MD
212-920-4140
White Plains, NY
Data Provided by:
        

Provided By:

MONDAY, July 27 (HealthDay News) -- Men who delay treatment for their early prostate cancer are not especially anxious about living with the disease, new Dutch research shows.

The evidence seems to contradict the assumption that living with untreated prostate cancer is nerve-wracking for most patients, according to Dr. Roderick van den Bergh, of Erasmus Medical Center in Rotterdam, and colleagues. The findings are published in the Sept. 1 issue of Cancer.

The researchers surveyed 129 men regarding their levels of depression and anxiety over their treatment decision. More than 80 percent scored favorably low and compared well emotionally with patients who had opted for more aggressive treatment, the study found.

Men who were in poor general health and those with neurotic personalities expressed higher levels of anxiety and distress, suggesting that factors other than cancer may impact a patient's emotional response, the researchers noted.

The study is especially useful in an era when prostate-specific antigen tests and other screening exams are uncovering prostate cancer at increasingly earlier stages. Many physicians practice a "wait-and-see" approach to treatment, saving the more aggressive therapies for when the cancer grows or spreads, according to information in a news release from the American Cancer Society.

Nationally, prostate cancer is one of the most common cancers and is expected to strike more than 190,000 men this year, and result in over 27,000 deaths, according to the American Cancer Society. But thanks to more effective screenings and treatments, while one in six U.S. men will develop prostate cancer during their lifetime, only one in 35 will actually die of the disease. What's more, there are more than 2 million men in the United States who have been diagnosed with prostate cancer at some point and are still alive today, according to the society.

More information

The U.S. National Cancer Institute has more on prostate cancer.

SOURCE: American Cancer Society, news release, July 27, 2009

Copyright © 2009 ScoutNews, LLC. All rights reserved.

Read Article at HealthDay.com

Related Articles
- Attack Of The Cancer Fighting Tomatoes Monsey NY
The active ingredient that makes tomatoes such a formidable opponent against cancer cells is the carotenoid called Lycopene. Lycopene is the natural red pigment found in tomatoes and tomato based products. The redder the tomato, the more lycopene is present. Read on and learn more.
- Diagnosis of Prostate Cancer Monsey NY
- Exercise for Prostate Cancer Monsey NY
- Head and Neck Cancer Treatment Monsey NY
- Hormone Therapy for Prostate Cancer Monsey NY
- Open Prostatectomy Versus Laparoscopic Procedure Monsey NY
- Hormone Therapy for Early Prostate Cancer Monsey NY
- Hormone Therapy for Lung Cancer Monsey NY
- Hormone Therapy for Breast Cancer Monsey NY
- Drug Combo Proves Powerful Against Lung Cancer Monsey NY